$NVAX·4

NOVAVAX INC · Mar 21, 5:50 PM ET

NOVAVAX INC 4

4 · NOVAVAX INC · Filed Mar 21, 2014

Insider Transaction Report

Form 4
Period: 2014-03-12
Modi Rajiv I.
Director10% Owner
Transactions
  • Sale

    Common Stock

    2014-03-21$4.69/sh1,000,000$4,690,0009,500,000 total(indirect: See footnote)
  • Sale

    Common Stock

    2014-03-19$5.17/sh1,000,000$5,170,00011,500,000 total(indirect: See footnote)
  • Sale

    Common Stock

    2014-03-20$4.99/sh1,000,000$4,990,00010,500,000 total(indirect: See footnote)
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.07 to $5.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.87 to $5.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.47 to $4.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F4]These shares are owned directly by Satellite Overseas (Holdings) Limited, which is a wholly owned subsidiary (except for directors' qualifying shares) of Cadila Pharmaceuticals Ltd. Cadila Pharmaceuticals Ltd is an indirect beneficial owner of the reported securities. These shares are held for convenience in the name of "SOHL, Inc., as nominee for Satellite Overseas (Holdings) Limited." SOHL, Inc., has no voting, dispositive or pecuniary interest in any such shares.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION